In essence, GLP-1 RAs might reconfigure the epigenetic characteristics of diabetic cells, offering significant therapeutic benefits in addressing IR and reversing harmful epigenetic alterations linked to aging and metabolic disorders
Neshatian L, Gibbons SJ, Farrugia G
For most people, including those with thyroid conditions (except MTC and MEN2), the benefits of treatment outweigh theoretical thyroid concerns that have not been confirmed in human studies
Even if you triple or quadruple your body's GLP-1 production, the hormone is degraded within minutes
After 68 weeks, half of the subjects using semaglutide lost 15% of their body weight, and almost a third lost 20%
Open questions researchers still want answered We need human clinical trials that test CLA and L-carnitine together to see whether an additive effect exists